1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Sickle-Cell Disease With Crisis: new trials by email Literature Review of Sickle-Cell Disease With Crisis trials Research Report on Sickle-Cell Disease With Crisis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigation Into the Use of BAH243 Lentiviral Vector for Gene Therapy in Treating Sickle Cell Disease Drug Product is administered by IV infusion following myeloablative conditioning with busulfan - Sickle Cell Disease, Sickle-Cell Disease With Crisis | Phase 1 / Phase 2 | Recruiting | Essen Biotech | 85 | 2024-08-01 | 2024-11-05 |
Anemia, Sickle Cell (1) · Vaso-Occlusive Crises (1)
Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemoglobinopathies (1)
Busulfan (1)
Essen Biotech (1)
China (1)